Analysts expect over 2021 rising revenue Carl Zeiss Meditec

Tomorrow the German company Carl Zeiss Meditec will publish its past quarters results. For this year the company from Jena could earn a total revenue around 1.63 billion euros. This is according to the average of the analysts' estimates. This is hugely more than 2021's revenue of 1.34 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2021

The analysts expect for 2021 a net profit of 235 million euros. The majority of the analysts expects for this year a profit per share of 2.63 euros. With this the price/earnings-ratio is an extreme 74.07.

Per share the analysts are expecting a dividend of 81 cents per share. Thus the dividend yield equals 0.42 percent. The average dividend yield of the pharmaceutical companies equals an attractive 1.52 percent.

Most recent target prices around 187 euros

Based on the current number of shares Carl Zeiss Meditec 's market capitalization equals 17.42 billion euros. 114

Historical stock prices Carl Zeiss Meditec

At 11.58 the stock trades 1.23 percent higher at 194.8 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.